Market closedNon-fractional
Viatris/VTRS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Viatris
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Ticker
VTRS
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Canonsburg, United States
Employees
33,000
Website
www.viatris.com
Viatris Metrics
BasicAdvanced
$14B
Market cap
-
P/E ratio
-$0.05
EPS
0.94
Beta
$0.48
Dividend rate
4.08%
Dividend yield
Price and volume
Market cap
$14B
Beta
0.94
Dividend rate
$0.48
Financial strength
Current ratio
1.665
Quick ratio
0.599
Long term debt to equity
80.305
Total debt to equity
89.789
Interest coverage (TTM)
3.71%
Management effectiveness
Return on assets (TTM)
2.71%
Return on equity (TTM)
-0.27%
Valuation
Price to revenue (TTM)
0.918
Price to book
0.7
Price to tangible book (TTM)
-1.59
Price to free cash flow (TTM)
7.046
Dividend yield (TTM)
4.08%
Growth
Revenue change (TTM)
-2.78%
Earnings per share change (TTM)
-103.18%
3-year revenue growth (CAGR)
3.74%
3-year earnings per share growth (CAGR)
-71.82%
3-year dividend per share growth (CAGR)
63.41%
What the Analysts think about Viatris
Analyst Ratings
Majority rating from 10 analysts.
Viatris Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.7B
-4.53%
Net income
$114M
-114.88%
Profit margin
3.10%
-115.54%
Viatris Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.75
$0.79
$0.62
$0.67
-
Expected
$0.71
$0.74
$0.65
$0.67
$0.68
Surprise
5.59%
6.72%
-4.12%
-0.50%
-
Viatris News
AllArticlesVideos
Viatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its Industry
GlobeNewsWire·8 hours ago
Idorsia announces financial results for the first half 2024
GlobeNewsWire·2 days ago
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
PRNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Viatris stock?
Viatris (VTRS) has a market cap of $14B as of July 27, 2024.
What is the P/E ratio for Viatris stock?
The price to earnings (P/E) ratio for Viatris (VTRS) stock is 0 as of July 27, 2024.
Does Viatris stock pay dividends?
Yes, the Viatris (VTRS) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.48 and the yield is 4.08%. Viatris has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Viatris dividend payment date?
The next Viatris (VTRS) dividend payment date is unconfirmed.
What is the beta indicator for Viatris?
Viatris (VTRS) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Viatris stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.